Literature DB >> 21331351

CARDIOVASCULAR RISK FACTORS AFFECT HIPPOCAMPAL MICROVASCULATURE IN EARLY AD.

Elizabeth Schwartz1, Bridget Wicinski, James Schmeidler, Vahram Haroutunian, Patrick R Hof.   

Abstract

There is growing clinical and neuropathologic evidence suggesting that cognitive decline in early Alzheimer's disease (AD) is aggravated by a synergistic relationship between AD and cerebrovascular disease associated with cardiovascular risk factors such as diabetes and hypertension. Here we used the stereologic "Space Balls" method to investigate the relationships between AD pathology and cardiovascular risk factors in postmortem human brains of patients with hypertension and diabetes in two groups - one consisting of cases with AD diagnosis and one of cases without. Hippocampal CA1 and CA3 microvasculature length density estimates were generated to characterize quantitatively the contribution of cardiovascular risk factors to the severity of neuropathologic changes. Our main finding is that the mean and variance of length density values in the AD group were significantly increased from the non-AD group, regardless of the absence or presence of a cardiovascular risk factor. An additional finding is that in the AD group without a risk factor, dementia severity correlated with amount of length density change in the CA1 field-this correlation did not exist in the AD groups with risk factors. Our findings suggest a role for cardiovascular risk factors in quantifiable change of hippocampal CA1 field microvasculature, as well as suggest a possible role of cardiovascular risk factors in altering microvasculature pathology in the presence of AD.

Entities:  

Year:  2010        PMID: 21331351      PMCID: PMC3039302          DOI: 10.2478/v10134-010-0040-9

Source DB:  PubMed          Journal:  Transl Neurosci        ISSN: 2081-6936            Impact factor:   1.757


  73 in total

1.  Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort.

Authors:  Adam M Brickman; Christiane Reitz; José A Luchsinger; Jennifer J Manly; Nicole Schupf; Jordan Muraskin; Charles DeCarli; Truman R Brown; Richard Mayeux
Journal:  Arch Neurol       Date:  2010-05

Review 2.  Update on hypertension and Alzheimer's disease.

Authors:  Ingmar Skoog; Deborah Gustafson
Journal:  Neurol Res       Date:  2006-09       Impact factor: 2.448

3.  Where vascular meets neurodegenerative disease.

Authors:  Julie A Schneider; David A Bennett
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

Review 4.  Human cerebral neuropathology of Type 2 diabetes mellitus.

Authors:  Peter T Nelson; Charles D Smith; Erin A Abner; Frederick A Schmitt; Stephen W Scheff; Gregory J Davis; Jeffrey N Keller; Gregory A Jicha; Daron Davis; Wang Wang-Xia; Adria Hartman; Douglas G Katz; William R Markesbery
Journal:  Biochim Biophys Acta       Date:  2008-08-22

5.  Free radical scavenging actions of hippocampal metallothionein isoforms and of antimetallothioneins: an electron spin resonance spectroscopic study.

Authors:  M V Kumari; M Hiramatsu; M Ebadi
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2000-05       Impact factor: 1.770

6.  Vascular changes in senile brains. A micro-angiographic study.

Authors:  O Hassler
Journal:  Acta Neuropathol       Date:  1965-10-04       Impact factor: 17.088

7.  Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study.

Authors:  J Heitner; D Dickson
Journal:  Neurology       Date:  1997-11       Impact factor: 9.910

8.  Stereologic analysis of microvascular morphology in the elderly: Alzheimer disease pathology and cognitive status.

Authors:  Constantin Bouras; Enikö Kövari; François R Herrmann; Claire-Bénédicte Rivara; Thomasina L Bailey; Armin von Gunten; Patrick R Hof; Panteleimon Giannakopoulos
Journal:  J Neuropathol Exp Neurol       Date:  2006-03       Impact factor: 3.685

Review 9.  Population-based neuropathological studies of dementia: design, methods and areas of investigation--a systematic review.

Authors:  Julia Zaccai; Paul Ince; Carol Brayne
Journal:  BMC Neurol       Date:  2006-01-09       Impact factor: 2.474

10.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088

View more
  4 in total

1.  The association between cardiovascular risk factors and progressive hippocampus volume loss in persons with Alzheimer's disease.

Authors:  Iryna Lobanova; Adnan I Qureshi
Journal:  J Vasc Interv Neurol       Date:  2014-12

2.  Heart disease as a risk factor for dementia.

Authors:  B Ng Justin; Michele Turek; Antoine M Hakim
Journal:  Clin Epidemiol       Date:  2013-04-26       Impact factor: 4.790

3.  Morphometry of the hippocampal microvasculature in post-stroke and age-related dementias.

Authors:  M J C Burke; L Nelson; J Y Slade; A E Oakley; A A Khundakar; R N Kalaria
Journal:  Neuropathol Appl Neurobiol       Date:  2014-04       Impact factor: 8.090

4.  Cardiovascular risk and hippocampal thickness in Alzheimer's disease.

Authors:  Markus Donix; Maria Scharf; Kira Marschner; Annett Werner; Cathrin Sauer; Antje Gerner; Josef A Nees; Shirin Meyer; Katharina L Donix; Rüdiger Von Kummer; Vjera A Holthoff
Journal:  Int J Alzheimers Dis       Date:  2013-10-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.